1 active not recruiting, 1 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Active not recruiting 1 |
Follow Darolutamide Oral Tablet: new trials by email Literature Review of Darolutamide Oral Tablet trials Research Report on Darolutamide Oral Tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer Ra223, Darolutamide Oral Tablet, Androgen Deprivation Therapy (ADT) - Metastatic Hormone-Sensitive Prostate Cance | Phase 2 | Not yet recruiting | Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD | 50 | 2026-09-01 | 2026-07-21 |
| COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer Darolutamide Oral Tablet, leuprorelin - Prostate Cancer | Phase 4 | Active not recruiting | Brazilian Clinical Research Institute | 144 | 2025-02-17 | 2026-10-30 |
| Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients Docetaxel, Apalutamide Oral Tablet, Enzalutamide Oral Tablet - Prostate Cancer, Hormone Sensitive Prostate Cancer | Recruiting | Santa Chiara Hospital | 3000 | 2016-12-16 | 2024-06-25 |
Prostatic Neoplasms (3) · Neoplasm Metastasis (1)
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD (1) · Brazilian Clinical Research Institute (1) · Santa Chiara Hospital (1)
Brazil (1) · Italy (1) · Spain (1)
David Lorente, M.D., Ph.D. (1) · Fernando C Maluf, MD (1) · Guillermo de Velasco, M.D., Ph.D. (1)